ArticleBMC biotechnology2026
Read-mapping signatures for molecular characterization of transgenic DNA insertions in paired-end Illumina data.
Article in BMC biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Read-mapping signatures for molecular characterization of transgenic DNA insertions in paired-end Illumina data.BMC biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transgenic crops undergo rigorous safety assessments prior to commercialization, with molecular characterization serving as a critical component of regulatory review. This process establishes the identity, copy number, sequence integrity, absence of unintended foreign DNA, and insert stability across breeding generations. While whole-genome sequencing (WGS) has emerged as a powerful alternative to Southern blotting, the lack of accessible interpretation frameworks can be an entry barrier to those who wish to understand this modernized experimental setup. We developed an analytical workflow based on mapped-read signatures to characterize T-DNA (transfer DNA) insertions using short-read WGS data. Simulated Illumina paired-end datasets representing diverse transformation outcomes were generated and analyzed to define five informative read classes, which when observed mapped to a reference transformation construct provide distinct signatures indicating transformation outcomes. These signatures were applied to identify insertion boundaries, copy number, structural anomalies, and potential contamination. Mapped-read signatures can reliably distinguish single-copy inserts, multiple insertions, backbone co-integrations, and structural rearrangements, aided by coverage profiles and mate-pair orientations. We present representative examples and a practical interpretation to guide practitioners new to WGS-based molecular characterization and regulators assessing these data. This framework standardizes interpretation of short-read paired-end WGS data for molecular characterization without prescribing specific software. The platform-agnostic approach ensures broad applicability while enhancing transparency in regulatory assessments.
Indexed as
Identifiers
42363144What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.